|
|
Volumn 7, Issue 2, 2008, Pages 174-179
|
|
Molecular basis of pathogenesis, prognosis and therapy in chronic lymphocytic leukaemia
a
|
|
Author keywords
Akt; Bcl2; BCR; CLL; MiRNA; p53; PI3K; PKR; Signal transduction; Src
|
|
Indexed keywords
4 [4 (4' CHLORO 2 BIPHENYLYLMETHYL) 1 PIPERAZINYL] N [4 [3 DIMETHYLAMINO 1 (PHENYLTHIOMETHYL)PROPYLAMINO] 3 NITROBENZENESULFONYL]BENZAMIDE;
ALEMTUZUMAB;
APRIL PROTEIN;
ATM PROTEIN;
B CELL ACTIVATING FACTOR;
B LYMPHOCYTE RECEPTOR;
BCL2 RELATED PROTEIN A1;
CHLORAMBUCIL;
CYCLOPHOSPHAMIDE;
FLICE INHIBITORY PROTEIN;
FLUDARABINE;
GELATINASE B;
IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;
MAMMALIAN TARGET OF RAPAMYCIN;
MICRORNA;
MITOGEN ACTIVATED PROTEIN KINASE 1;
MITOGEN ACTIVATED PROTEIN KINASE 3;
PROTEIN BCL 2;
PROTEIN BCL X;
PROTEIN KINASE B;
PROTEIN KINASE ZAP 70;
PROTEIN MDM2;
PROTEIN P53;
RAPAMYCIN;
RAS PROTEIN;
REACTIVE OXYGEN METABOLITE;
RITUXIMAB;
ROSCOVITINE;
TELOMERASE;
UNINDEXED DRUG;
B LYMPHOCYTE;
CHROMOSOMAL INSTABILITY;
CHROMOSOME 11Q;
CHROMOSOME 12;
CHROMOSOME 13Q;
CHROMOSOME 14Q;
CHROMOSOME 17;
CHROMOSOME 17P;
CHROMOSOME 18Q;
CHROMOSOME 20Q;
CHROMOSOME 2Q;
CHROMOSOME 4Q;
CHROMOSOME ABERRATION;
CHRONIC LYMPHATIC LEUKEMIA;
GENE MUTATION;
HUMAN;
IMMUNOGLOBULIN GENE;
IMMUNOGLOBULIN VARIABLE REGION;
LEUKEMOGENESIS;
NONHUMAN;
PROGNOSIS;
REVIEW;
|
|
EID: 42549133659
PISSN: 15384047
EISSN: 15558576
Source Type: Journal
DOI: 10.4161/cbt.7.2.5262 Document Type: Review |
|
Times cited : (33)
|
|
References (91)
|
